On Wednesday, July 29, Hologic HOLX will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
Earnings and Revenue
Analysts predict Hologic will report earnings of $0.37 per share on revenue of $607.71 million. Hologic reported a per-share profit of $0.630 when it published results during the same quarter last year. Sales in that period totaled $852.40 million. If the company were to report inline earnings when it publishes results Wednesday, quarterly profit would be down 41.27%. Sales would be down 18.69% on a year-over-year basis. Here's how the Hologic's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
---|---|---|---|---|
EPS Estimate | 0.57 | 0.61 | 0.65 | 0.61 |
EPS Actual | 0.57 | 0.61 | 0.65 | 0.63 |
Revenue Estimate | 747.36 M | 839.82 M | 845.73 M | 835.74 M |
Revenue Actual | 756.10 M | 850.50 M | 865.80 M | 852.40 M |
Stock Performance
For a full 12 months, the return has risen by 21.72%. Given that these returns are generally positive, long-term shareholders are probably relaxed going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Don't be surprised to see the stock move on comments made during its conference call. Hologic is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/e9eoejo2
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.